Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1-Reference-Cited by-同舟云学术

Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1

Published:2011-07 Issue:1-3 Volume:55 Page:10-16
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Fadini Gian Paolo,Avogaro Angelo

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference75 articles.

1. Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control;Anagnostis;Diabetes Obes. Metab.,2011

2. The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors;Augustyns;Curr. Med. Chem.,1999

3. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways;Ban;Circulation,2008

4. Glucagon-like peptide (GLP)-1(9–36)amide-mediated cytoprotection is blocked by exendin(9–39) yet does not require the known GLP-1 receptor;Ban;Endocrinology,2010

5. Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells;Bauvois;Oncogene,2000

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative risk of infection of medications used for type 2 diabetes;Expert Opinion on Drug Safety;2024-09-11

2. Association of Sodium-Glucose Cotransporter-2 Inhibitors vs Dipeptidyl Peptidase-4 Inhibitors With Pneumonia, COVID-19, and Other Adverse Respiratory Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis;Canadian Journal of Diabetes;2024-08

3. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM);European Journal of Medicinal Chemistry;2024-06

4. Vildagliptin Nephroprotective Effect in Rats Model with Cisplatin-Induced Nephrotoxicity;Journal of Contemporary Medical Sciences;2024-02-26

5. The entero-insular axis and metabolic syndrome;Metabolic Syndrome;2024